Evidence map›Paper›PMID 34462612›Full record

ReviewTrends in analytical chemistry : TRAC2021

Paper-based analytical devices for virus detection: Recent strategies for current and future pandemics.

Tugba Ozer, Charles S Henry

Abstract readReview
In one paragraph

Review in Trends in analytical chemistry : TRAC, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Tetrahedral DNA framework assisted rotational paper-based analytical device for differential detection of SARS-CoV-2 and influenza A H1N1 virus.Microchemical journal : devoted to the application of microtechniques in all branches of science · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Microfluidic Approaches for Affinity-Based Exosome Separation.International journal of molecular sciences · 2022
    Review
  18. Engineering carbon nanotubes for sensitive viral detection.Trends in analytical chemistry : TRAC · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tugba OzerYildiz Technical University, Faculty of Chemical-Metallurgical Engineering, Department of Bioengineering, 34220, Istanbul, Turkey.
Charles S HenryColorado State University, Department of Chemistry, Fort Collins, CO, 80523, USA.

Funding

Paper-Analytical Device for Saliva Biomarker DiagnosticsR21EB030349 · NIBIB · COLORADO STATE UNIVERSITY · PI HENRY, CHARLES S · 2020 to 2020
$371k
NIBIB NIH HHS R21 EB030349
6 · The paper itself

Abstract

The importance of user-friendly, inexpensive, sensitive, and selective detection of viruses has been highlighted again due to the recent Coronavirus disease 2019 (COVID-19) pandemic. Among the analytical tools, paper-based devices (PADs) have become a leading alternative for point-of-care (POC) testing. In this review, we discuss the recent development strategies and applications in nucleic acid-based, antibody/antigen-based and other affinity-based PADs using optical and electrochemical detection methods for sensing viruses. In addition, advantages and drawbacks of presented PADs are identified. Current state and insights towards future perspectives are presented regarding developing POC diagnosis platform for COVID-19. This review considers state-of-the-art technologies for further development and improvement in PADs performance for virus detection.

Indexed as

COVID-19ElectrochemicalInfectious diseasesNanomaterialsOpticalPaper-basedPoint of careSARS-CoV-2Virus detection

Identifiers

PMID34462612
PMCPMC8387141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.